Gaush Meditech Ltd (HKG:2407)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.12
+0.22 (4.49%)
Jul 31, 2026, 3:37 PM HKT

Gaush Meditech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
96.1992.39173.52-349.62-190.45
Depreciation & Amortization
89.2680.674.6964.6358.84
Other Amortization
1.61.341.281.121.22
Loss (Gain) From Sale of Assets
0.090.68-0.150.670.05
Asset Writedown & Restructuring Costs
2.3623.26---
Loss (Gain) From Sale of Investments
-2.81-3.72-3.96-0.01-0.09
Provision & Write-off of Bad Debts
-0.44-0.56-1.24-2.244.76
Other Operating Activities
-31.9117.2333.51501.67365.18
Change in Accounts Receivable
5.33-16.4319.688.2620.49
Change in Inventory
-5.68-5.11-48.74-41.7838.59
Change in Accounts Payable
10.21-19.6722.1-4.18-42.57
Change in Unearned Revenue
0.69-21.71-7.5139.8-27.6
Change in Other Net Operating Assets
-20.66-40.53-14.14-4.86-68.64
Operating Cash Flow
144.23107.78249.04234.42164.49
Operating Cash Flow Growth
33.82%-56.72%6.24%42.52%26.53%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-22.77-14.67-34.92-45.4-26.55
Sale of Property, Plant & Equipment
0.0100.01--
Cash Acquisitions
-2.78-23.79-9.4-105.77
Sale (Purchase) of Intangibles
-10.99-66.55-10.67-2.62-1.5
Investment in Securities
97.6280.19-81.11-92.7-
Other Investing Activities
-40.2743.35-31.554.682.11
Investing Cash Flow
20.8218.55-167.65-136.0479.84

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
82.8127.527.9257.7266.08
Long-Term Debt Repaid
-209.73-135.56-153.08-339.94-104.96
Net Debt Issued (Repaid)
-126.92-108.04-145.16-282.21-38.88
Issuance of Common Stock
--1.55327.829.07
Repurchase of Common Stock
-24.58-12.58---489.73
Common Dividends Paid
-39.78-148.56---
Other Financing Activities
-15.33-33.93-46.32-42.51-86.73
Financing Cash Flow
-206.6-303.09-189.943.0872.84

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
41.12-20.55.7211.07-15.66
Net Cash Flow
-0.43-197.26-102.83112.53301.51

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
121.4693.12214.11189.03137.94
Free Cash Flow Growth
30.44%-56.51%13.27%37.04%7.57%
Free Cash Flow Margin
8.80%6.52%15.23%15.08%10.63%
Free Cash Flow Per Share
0.840.631.451.951.44
Levered Free Cash Flow
83.19-7.59123.94137.2-9.58
Unlevered Free Cash Flow
95.4415.35155.56163.8742.63

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
17.3733.3842.2738.8276.09
Cash Income Tax Paid
72.9489.7185.4794.4997.43
Change in Working Capital
-10.11-103.44-28.62-2.76-79.74